Webinar series: Mobilise-D presents its hip fracture cohort BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Webinar series: Mobilise-D presents its four patient cohorts BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Mobilise-D Workshop at the International Conference on Ambulatory Monitoring of Physical Activity and Movement (ICAMPAM) BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA “The End” of Work Package 2 – Algorithm development and technical validation BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA Mobilise-D presentations at DIA Europe 2022 BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA The Mobilise-D Public Webinar Series starts in February 2022 BREAKING
NEWS Read more Webinar 10 - Chronic Obstructive Pulmonary Disease (COPD) LATEST
VIDEO More Videos Plos One Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol Mikolaizak et al. (2022) on behalf of Mobilise-D consortium Other publications LATEST
PUBLICATION SOCIAL MEDIA

Connecting digital mobility assessment to clinical outcomes
for regulatory and clinical endorsement

What?

What?

Mobilise-D is a 5-year, IMI-funded project that will produce validated and accepted digital mobility outcomes to monitor daily life gait of people with different mobility problems, with the goal to improve follow-up and personalized care.

About Us

How?

How?

Mobilise-D will perform a technical and clinical validation of a sensor-algorithm pair in different patient groups. We maintain close dialogue with the European Medicines Agency (EMA) to facilitate the process of regulatory approval.

About Us

Who?

Who?

The Mobilise-D consortium consists of 34 partners from Europe and the USA. Over 200 professionals with technical, clinical, and regulatory expertise will work together to bring digital mobility outcomes to the clinic.                                                                  

About Us

Mobility – how well we walk – is an important marker of health; a slow walking speed is associated with greater mortality, morbidity, cognitive decline, dementia, and fall risk. As the population ages, the number of people experiencing mobility challenges is expected to rise. However, accurately assessing people’s mobility, especially in the real daily life world, is far from easy.

Mobilise-D will develop a comprehensive system to monitor and evaluate people’s gait based on digital technologies, including sensors worn on the body. The project focuses on conditions which often affect mobility, namely chronic obstructive pulmonary disease, Parkinson’s disease, multiple sclerosis, hip fracture recovery, and congestive heart failure.

The Mobilise-D results will help to improve the accurate assessment of daily life mobility in clinical trials and patient treatment, thereby contributing to improved and more personalised care.

Patient Groups

Mobilise-D will focus on five different patient groups that together represent respiratory problems (chronic obstructive pulmonary disease – COPD), neurodegenerative conditions (Parkinson’s disease – PD), neuroinflammatory problems (multiple sclerosis – MS), osteoporosis and sarcopenia (hip fracture recovery/proximal femoral fracture – PFF), and cardiac pathology (congestive heart failure – CHF).

These patient groups cover a range of walking speed, mobility challenges, and potential events that we care about, such as improving versus worsening of function, falls, hospitalisation, nursing home admission, and death. Furthermore, these patient groups will be followed at 12 different sites across Europe, ensuring a good geographical representation and covering a diverse representation of health care organisation, such as in- versus outpatient care, as well as public versus private health services.

Read More

Twitter Feed

Mobilise-D @Mobilise_D

New year, new Advent Calendar✨

#MobiliseD #mobility #wearables #digitalhealth #Research #Dissemination https://t.co/d8IswVuxeb
View on Twitter
Mobilise_D photo
4
6
Mobilise-D @Mobilise_D

📢 Hip Fracture Webinar 📢

If you want to better understand #mobility after #hipfracture and how digital mobility outcomes can become a game changer in the follow-up of these patients, don’t miss out on our upcoming free webinar!

📅 Dec 7
⌚ 16:00 CET

https://t.co/GAbLQuMaAq https://t.co/tfL4uidFlP
View on Twitter
Mobilise_D photo
3
6

Latest News

Webinar series: Mobilise-D presents its hip fracture cohort

Mobilise-D will present its hip fracture cohort on Wednesday, December 7. Regaining gait function after a hip fracture is key to recovery and one of the main aims of treatment and rehabilitation. Yet, many hip fracture patients fail to regain former levels of mobility and activity. What underlies recovery and how can we optimise it?…

Read more

Upcoming Events

No event found!
Sign up for our Newsletter!